DOI:
10.1055/s-00037682
International Journal of Epilepsy
LinksClose Window
References
Krauss GL, Perucca E, Ben-Menachem E. et al.
Perampanel, a selective, noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial-onset seizures: interim results from phase 3, extension study 307.
Epilepsia
54 January (1) 2013; 126-134
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.